Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Gilead Sciences Inc (GILD)

Gilead Sciences Inc (GILD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 95,859,184
  • Shares Outstanding, K 1,254,373
  • Annual Sales, $ 22,449 M
  • Annual Income, $ 5,386 M
  • 60-Month Beta 0.70
  • Price/Sales 4.29
  • Price/Cash Flow 10.52
  • Price/Book 4.36

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate 1.57
  • Number of Estimates 9
  • High Estimate 1.92
  • Low Estimate 1.34
  • Prior Year 1.72
  • Growth Rate Est. (year over year) -8.72%

Price Performance

See More
Period Period Low Period High Performance
1-Month
71.91 +5.15%
on 06/12/20
78.39 -3.55%
on 06/10/20
-1.36 (-1.77%)
since 06/08/20
3-Month
71.91 +5.15%
on 06/12/20
85.79 -11.87%
on 04/17/20
+0.62 (+0.83%)
since 04/08/20
52-Week
60.89 +24.17%
on 10/03/19
85.97 -12.05%
on 03/19/20
+8.13 (+12.05%)
since 07/08/19

Most Recent Stories

More News
Biotech Stock Roundup: REGN Initiates Coronavirus Study, NVAX Surges & More

The biotech sector remains in focus with updates on coronavirus treatments and other pipeline updates.

REGN : 640.34 (-0.08%)
GILD : 75.61 (-1.06%)
AMGN : 251.59 (-0.62%)
NVAX : 98.30 (-5.99%)
CRVS : 5.37 (+8.38%)
Gilead Sciences Presents Survey Findings on PrEP Access and Utilization in the U.S. During COVID-19 Shelter-in-Place Orders

--- Separate Clinical Data Presented Suggest no Reported Increase in Sexual Health Risk Behavior From Baseline Among DISCOVER Trial Study Participants -

GILD : 75.61 (-1.06%)
Regeneron Initiates Studies on Experimental Coronavirus Drug

Regeneron (REGN) announces initiation of late-stage studies evaluating REGN-COV2 for the treatment and prevention of COVID-19.

REGN : 640.34 (-0.08%)
SNY : 51.52 (+0.17%)
GILD : 75.61 (-1.06%)
LLY : 169.13 (+1.43%)
Gilead Sciences (GILD) Stock Moves -0.44%: What You Should Know

Gilead Sciences (GILD) closed the most recent trading day at $76.42, moving -0.44% from the previous trading session.

GILD : 75.61 (-1.06%)
Here's Why Lilly (LLY) Stock is Up Despite Coronavirus Crisis

Lilly's (LLY) shares are up this year mainly due to rapid progress in its efforts to make medicines/antibodies to treat COVID-19.

RHHBY : 44.1200 (+1.17%)
GILD : 75.61 (-1.06%)
LLY : 169.13 (+1.43%)
ABBV : 99.52 (+0.17%)
Zacks.com featured highlights include: Bristol-Myers Squibb, Vale, Gilead Sciences, Kroger and Delek Logistics Partners

Zacks.com featured highlights include: Bristol-Myers Squibb, Vale, Gilead Sciences, Kroger and Delek Logistics Partners

GILD : 75.61 (-1.06%)
BMY : 59.56 (-1.21%)
VALE : 10.76 (+2.77%)
KR : 32.42 (-3.74%)
DKL : 24.06 (+0.71%)
5 High Dividend-Yielding S&P 500 Stocks Amid Coronavirus Woes

At a time when the coronavirus outbreak has hampered steady stream of income for many, investing in high dividend-yielding stocks can be rewarding. We have picked 5 S&P 500 stocks worth considering.

FAST : 43.02 (-2.36%)
GILD : 75.61 (-1.06%)
KLAC : 204.51 (+0.90%)
GIS : 62.94 (-0.06%)
CLX : 225.57 (+0.79%)
4 Solid Stocks to Buy on Renewed Hopes of Coronavirus Vaccine

The past few months have seen pharmaceutical companies making every effort to develop a vaccine for the novel coronavirus.

DVAX : 9.42 (+6.80%)
GILD : 75.61 (-1.06%)
MRNA : 61.58 (+0.80%)
LLY : 169.13 (+1.43%)
GSK : 40.73 (+0.87%)
Gilead Sciences Rises 1.14% on Heavy Volume: Watch For Potential Pullback

Gilead Sciences (NASDAQ:GILD) traded in a range yesterday that spanned from a low of $76.07 to a high of $77.66. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of...

GILD : 75.61 (-1.06%)
5 High Earnings Yield Stocks for a Winning Portfolio

Earnings yield is very important in comparing a stock with other stocks and with fixed income securities. A stock with higher earnings yield fetches better returns.

GILD : 75.61 (-1.06%)
BMY : 59.56 (-1.21%)
VALE : 10.76 (+2.77%)
KR : 32.42 (-3.74%)
DKL : 24.06 (+0.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade GILD with:

Business Summary

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products...

See More

Key Turning Points

2nd Resistance Point 77.92
1st Resistance Point 76.76
Last Price 75.61
1st Support Level 74.69
2nd Support Level 73.78

See More

52-Week High 85.97
Fibonacci 61.8% 76.39
Last Price 75.61
Fibonacci 50% 73.43
Fibonacci 38.2% 70.47
52-Week Low 60.89

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar